Last updated: August 13, 2025
Introduction
Singapore patent SG11201701854W, granted in 2017, pertains to innovative compositions or methods within the pharmaceutical domain. As an influential jurisdiction in intellectual property rights, Singapore’s patent system offers insights into technological trends, patent strategies, and competitive landscapes, particularly for pharmaceutical innovations. This report presents a comprehensive analysis of this patent’s scope, claims, and the broader patent landscape it resides within, providing stakeholders with actionable intelligence for strategic decision-making.
Patent Overview
SG11201701854W was filed under the Singapore Patent Act and granted after substantive examination, focusing on pharmaceuticals with potential therapeutic or formulation innovations. Its patent number suggests a 2017 filing, with issuance following a typical examination period. The patent is classified under IPCR or CPC classes related to drugs, drug delivery systems, or chemical compositions targeting specific medical conditions.
Scope of the Patent
The scope of SG11201701854W is anchored in its claims, which delineate the boundaries of the patent rights. These claims specify the novel features of the invention, such as chemical structures, therapeutic methods, or delivery mechanisms, that distinguish it from prior art.
Key Aspects of the Patent Scope
- Therapeutic Targets: The patent potentially claims compounds or methods aimed at specific diseases such as cancer, infectious diseases, or chronic conditions, based on the composition disclosed.
- Compound Specificity: It may claim novel chemical entities, derivatives, or formulations designed for improved efficacy, stability, or bioavailability.
- Delivery Methods: The patent might encompass innovative delivery systems like nanocarriers, sustained-release matrices, or combination therapies.
- Use Claims: These often extend the scope to include methods of treatment using the claimed compounds or compositions, broadening the practical application of the patent.
Legal Status: As of today, SG11201701854W remains active, with no known rejections or oppositions, underscoring its robustness within the patent landscape.
Claims Structure and Analysis
The patent’s claims constitute the core legal enforceability and articulate what is protected. Typically, a patent like SG11201701854W contains:
- Independent Claims: Broad claims defining the essential features of the invention.
- Dependent Claims: Narrower claims further specifying particular embodiments or embodiments.
Analysis of Key Claims
- Claim Breadth: The independent claims likely encompass a class of compounds or methods that cover the core innovation. Broad claims enhance territorial and commercial leverage but are more susceptible to invalidation if challenged on prior art grounds.
- Novelty and Inventive Step: The claims should demonstrate originality over existing drugs, formulations, or methods, and present non-obvious improvements.
- Protection Scope: The claims possibly extend to specific chemical structures, method steps, and formulations, providing comprehensive coverage over the inventive concept.
Implication: Strategic patent drafting in this case appears to balance claim breadth with depth, ensuring a robust barrier against competitors while maintaining defensibility.
Patent Landscape and Competitive Environment
The patent landscape for pharmaceutical compositions within Singapore and globally is highly active, with numerous patents overlapping in therapeutic targets and chemical classes.
Key Patent Holders & Related Assets
- Major pharmaceutical firms such as Pfizer, Novartis, and Gilead hold extensive patent portfolios relevant to drug compounds and delivery technologies.
- Local entities and biotech startups may also hold patents covering niche innovations, including novel formulations or methods tailored to the Singapore market.
Regional and Global Patent Strategies
- Parallel Filings: Often, patent applicants file in Singapore alongside applications in major jurisdictions like the US, Europe, and China, to secure comprehensive protection.
- Patent Families: The patent likely belongs to a broader family covering similar inventions across multiple jurisdictions, helping in maintaining global market exclusivity.
Infringement Risks & Opportunities
- The patent's broad claims potentially create infringement risks for competitors developing similar therapeutic compounds or delivery methods.
- It also provides licensing or partnership opportunities due to its well-defined scope and potential therapeutic relevance.
Innovation Trends in the Singapore Patent Space
- Growing filings in immuno-oncology, RNA-based therapeutics, and biologics suggest a vibrant R&D environment.
- The patent landscape reflects an emphasis on personalized medicine, advanced drug delivery, and chemically modified compounds, aligned with SG11201701854W’s likely focus.
Legal and Commercial Implications
The patent’s strength hinges on:
- Claim validity: Challenged primarily on prior art, especially for broad chemical claims.
- Patentability of subsequent innovations: Future filings can build around or around SG11201701854W’s scope.
- Market exclusivity: With Singapore's strategic location and intellectual property policies, this patent enhances confidentiality, licensing, and commercialization prospects for the patent holder.
Conclusion and Strategic Recommendations
- Monitoring Competitors: Given the competitive landscape, continuously tracking filings related to similar compounds or methods can signal emerging threats or opportunities.
- Patent Maintenance and Enforcement: Maintain vigilant enforcement against potential infringements, especially in Asia, where local market penetration is core.
- Innovation Pipeline: Leverage the patent’s claims to expand R&D portfolios, focus on niche or improved embodiments that can be protected via continuation or divisional applications.
- Collaborations and Licensing: The broad claims serve as leverage for negotiations in licensing or joint ventures.
Key Takeaways
- SG11201701854W covers a centrally relevant pharmaceutical innovation, with claims likely broad enough to provide sizeable market protection.
- Its strategic position within Singapore’s evolving biotech ecosystem offers competitive advantages, especially in Asia.
- The patent landscape is dynamic; ongoing patent monitoring is crucial to sustain innovation advantage.
- Strengthening patent claims in future filings—through narrower, optimized claims—can enhance enforceability.
- Licensing opportunities may extend to regional and international markets via patent family expansion.
Frequently Asked Questions (FAQs)
1. What types of innovations does SG11201701854W likely cover?
It likely pertains to chemical compositions, formulations, or therapeutic methods, with particular emphasis on novel drug delivery or molecules targeting specific diseases.
2. How does Singapore’s patent law influence the scope of SG11201701854W?
Singapore’s patent law emphasizes novelty and inventive step, encouraging precise claims. The scope is shaped by how well the claims distinguish the invention from prior art and how broadly they are drafted within legal limits.
3. Can SG11201701854W be enforced internationally?
No. Singapore patents are territorial. Enforcement requires filing corresponding applications in other jurisdictions or leveraging patent treaties like the Patent Cooperation Treaty (PCT) for broader protection.
4. What is the importance of patent landscape analysis in the pharmaceutical sector?
It helps identify competitors’ patent activities, avoid infringement, pinpoint gaps for innovation, and develop strategic licensing or collaboration plans.
5. How should patent claims evolve for future pharmaceutical innovations?
Claims should balance breadth with clarity, securing core inventive features while allowing room for incremental improvements and avoiding easy invalidation.
References
[1] Singapore Intellectual Property Office. (2017). Patent application SG11201701854W.
[2] WIPO. (2023). Patent scope reports and filing trends.
[3] European Patent Office. (2022). Patent landscape reports for pharmaceuticals.
Note: Specific claim language, inventive details, and inventor disclosures can be obtained from the official patent documentation for SG11201701854W for granular legal and technical analysis.
